Overview of Dr. Agha
Dr. Mounzer Agha is a hematologist in Pittsburgh, PA and is affiliated with multiple hospitals in the area, including UPMC Presbyterian, UPMC Magee-Womens Hospital, UPMC Passavant, UPMC St. Margaret, and UPMC Presbyterian Shadyside - Shadyside. He received his medical degree from University of Aleppo Faculty of Medicine and has been in practice 34 years. Dr. Agha accepts several types of health insurance, listed below. He is one of 21 doctors at UPMC Presbyterian and one of 12 doctors at UPMC Magee-Womens Hospital who specialize in Hematology.
Education & Training University of Washington FELLOWSHIP Penn State University RESIDENCY University of Aleppo Faculty of Medicine MEDICAL_SCHOOL Certifications & Licensure Clinical Trials Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source Start of enrollment: 2014 Jul 01 Farah, R.J. A Phase II Study of Clofarabine and Cytarabine for Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Persistent Disease After Treatment With an Anthracycline and Cytarabine Start of enrollment: 2013 Oct 01 Im, A.P.,Boyiadzis, M.,Agha, M.E.,Redner, R.L. Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 Start of enrollment: 2010 Sep 01 Cohen, A.D.,Agarwal, A.,Krishnan, A.,Costello, C.,Block, C.,Gasparetto, C.,Gasparetto, C.,Couriel, D.,Avigan, D.,Hurd, D.,Weckstein, D.,Scott, E.,Basile, F.,Cornell, F.,Hildebrant, G.,Sidhu, G.,Hassoun, H... Phase I/II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy (UPCI 07-154) Start of enrollment: 2008 Sep 01 Boyiadzis, M. Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma Start of enrollment: 2004 Aug 01 Freedman, A.,Nademanee, A.,Berryman, B.,Hosing, C.,Flowers, C.,Ball, E.,Laport, G.G.,Lazarus, H.,Ferrara, J.,Mason, J.,Wade, J.,Jansen, J.s.,Kurtzberg, J.,DiPersio, J.,McCarty, J.,Wingard, J.,McGuirk, J.,... Comparing Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation in Individuals With Hematologic Cancers Start of enrollment: 2004 Jan 01 Kassim, A.,Woolfrey, A.,Nademanee, A.,Horn, B.,Toze, C.,Smith, C.,Cutler, C.,Weisdorf, D.,Avigan, D.E.,Hurd, D.,Waller, E.,Agura, E.,Ball, E.,Nemecek, E.,Lazarus, H.,Sahdev, I.,Ferrara, J.,Jansen, J.s.,Ro... Publications & Presentations PubMed
Multifocal Necrotizing Leukoencephalopathy With Preferential Microglia Toxicity in a Patient Treated With Chimeric Antigen Receptor T-Cells and Review of the Literature.
Marker, D. F., Kofler, J. K., Mettenburg, J. A., Agha, M. E., Wiley, C. A.> ;Journal of neuropathology and experimental neurology. 2020 Sep 22
More on Blastic Plasmacytoid Dendritic-Cell Neoplasms.
Agha, M. E., Monaghan, S. A., Swerdlow, S. H.> ;The New England journal of medicine. 2019 Feb 15
Venetoclax in a Patient with a Blastic Plasmacytoid Dendritic-Cell Neoplasm.
Agha, M. E., Monaghan, S. A., Swerdlow, S. H.> ;The New England journal of medicine. 2018 Oct 12 Join now to see all Press Mentions Outpatient CAR-T Therapy May Offer Cost Savings, but More Data Are Needed May 26, 2020 Rethinking Treatment Schemas in Relapsed/Refractory Multiple Myeloma July 10, 2019 OncLive® Presents State of the Science Summit™ June 03, 2019 Join now to see all Insurance Accepted
Aetna Choice POS II
Aetna HMO BCBS Blue Card PPO CIGNA HMO CIGNA Open Access CIGNA PPO First Choice Great West PPO Health Net Oregon PPO HealthAmerica HealthAssurance PPO
Highmark BCBS ClassicBlue
Highmark BCBS PPOBlue Humana ChoiceCare Network PPO Multiplan PHCS PPO Multiplan PPO ODS Network Regence Washington - Preferred Provider Network United Healthcare - Direct Choice Plus POS United Healthcare - Direct Options PPO Please verify your coverage with the provider's office directly when scheduling an appointment